✦ LIBER ✦

PUK16 COST-EFFECTIVENESS ANALYSIS OF SOLIFENACIN FLEXIBLE DOSING IN PATIENTS WITH OVERACTIVE BLADDER SYMPTOMS IN FOUR NORDIC COUNTRIES

✍ Scribed by I Milsom; J Wickstrøm; PB Poulsen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness analysis of solifenac

✍ IAN MILSOM; SUSANNE AXELSEN; SIGURD KULSENG-HANSEN; ANDERS MATTIASSON; CARL GUST 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 78 KB

PUK21 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; J. Nazir 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PUK10 Cost-Effectiveness Analysis of Sol

✍ W.M. Hart; V. Munro; P. Retsa 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Efficacy of solifenacin in patients with

✍ Millard, R. J.; Halaska, M. 📂 Article 📅 2005 🏛 Informa plc 🌐 English ⚖ 411 KB

PUK6 COST-EFFECTIVENESS ANALYSIS OF SACR

✍ M Van Genugten; R Leong; M Brosa; F Stauble 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

PUK11 A COST-UTILITY ANALYSIS OF SOLIFEN

✍ L Cardozo; A Thorpe; M Grishchenko; MK Sidhu 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB